norfloxacin and spectinomycin

norfloxacin has been researched along with spectinomycin in 14 studies

Research

Studies (14)

Timeframe	Studies, this research(%)	All Research%
pre-1990	6 (42.86)	18.7374
1990's	0 (0.00)	18.2507
2000's	3 (21.43)	29.6817
2010's	5 (35.71)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Al-Momani, W; Antunes, NT; Assunção, P; Ayling, RD; Mercier, P; Poveda, JB; Rosales, RS; Tavío, MM	1
Bammert, GF; Banitt, LS; Barbachyn, MR; Boyle, TP; Bundy, GL; Dolak, LA; Ford, CW; Graber, DR; Hamel, JC; Han, F; Harris, DW; Hromockyj, AE; Hurd, AR; Kamilar, GM; Marotti, KR; Martin, GE; Miller, AA; Mott, JE; Munzner, JB; Palmer, JR; Ruble, JC; Seest, EP; Skepner, JE; Sweeney, MT; Zhong, WZ; Zurenko, GE	1
Awuah, E; Barker, C; Brown, ED; Capretta, FA; Das, R; Gerritsma, DA; Lebert, J; Melacini, G; Pathania, R; Zlitni, S	1
Mima, T; Schweizer, HP	1
Bohnert, JA; Karamian, B; Nikaido, H	1
Dhamdhere, G; Krishnamoorthy, G; Zgurskaya, HI	1
Allison, SE; Barker, CA; Brown, ED; Capretta, AA; Das, R; Melacini, G; Nguyen, ND; Zlitni, S	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Gill, CJ; Ponticas, S; Shungu, DL	1
Bogaerts, J; Dekegel, M; Piot, P; Van Dyck, E; Vandepitte, J; Vanhoof, R	1
O-Prasertsawat, P; Phiromsawat, S; Pongthai, S; Srisupandit, S; Sugkraroek, P	1
Bamberg, P; Ho, B; Lee, CT; Panikabutra, K	1
Berg, SW; Colby, SD; Crider, SR; Harrison, WO; Kerbs, SB; Miller, LK	1
Peeters, M; Piot, P; Van Dyck, E	1

Reviews

1 review(s) available for norfloxacin and spectinomycin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

1 trial(s) available for norfloxacin and spectinomycin

Article	Year
Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference. Genitourinary medicine, 1988, Volume: 64, Issue:4 Topics: Administration, Oral; Adolescent; Adult; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Middle Aged; Neisseria gonorrhoeae; Norfloxacin; Patient Acceptance of Health Care; Penicillinase; Spectinomycin	1988

Article

Year

Single dose oral norfloxacin or intramuscular spectinomycin to treat gonorrhoea (PPNG and non-PPNG infections): analysis of efficacy and patient preference.

Genitourinary medicine, 1988, Volume: 64, Issue:4

Topics: Administration, Oral; Adolescent; Adult; Female; Gonorrhea; Humans; Injections, Intramuscular; Male; Middle Aged; Neisseria gonorrhoeae; Norfloxacin; Patient Acceptance of Health Care; Penicillinase; Spectinomycin

1988

Other Studies

12 other study(ies) available for norfloxacin and spectinomycin

Article	Year
In vitro susceptibilities of Mycoplasma putrefaciens field isolates. Antimicrobial agents and chemotherapy, 2007, Volume: 51, Issue:9 Topics: Anti-Bacterial Agents; France; Humans; Jordan; Lincomycin; Macrolides; Microbial Sensitivity Tests; Mycoplasma; Mycoplasma Infections; Tetracycline Resistance	2007
Discovery and characterization of QPT-1, the progenitor of a new class of bacterial topoisomerase inhibitors. Antimicrobial agents and chemotherapy, 2008, Volume: 52, Issue:8 Topics: Animals; Anti-Bacterial Agents; Area Under Curve; Bacteria; Bacterial Infections; Bacterial Proteins; Cell Line; Cell Proliferation; Metabolic Clearance Rate; Mice; Microbial Sensitivity Tests; Molecular Structure; Staphylococcus aureus; Stereoisomerism; Topoisomerase II Inhibitors	2008
Chemical genomics in Escherichia coli identifies an inhibitor of bacterial lipoprotein targeting. Nature chemical biology, 2009, Volume: 5, Issue:11 Topics: Anti-Bacterial Agents; Cell Division; Chromatography, Liquid; Cycloserine; Doxorubicin; Drug Resistance, Multiple; Escherichia coli; Escherichia coli Proteins; Fosfomycin; Genes, Bacterial; Genome, Bacterial; Genomics; Lipoproteins; Mass Spectrometry; Molecular Chaperones; Periplasmic Binding Proteins; Pseudomonas aeruginosa; Sulfamethoxazole; Suppression, Genetic; Trimethoprim	2009
The BpeAB-OprB efflux pump of Burkholderia pseudomallei 1026b does not play a role in quorum sensing, virulence factor production, or extrusion of aminoglycosides but is a broad-spectrum drug efflux system. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:8 Topics: Aminoglycosides; Anti-Bacterial Agents; Bacterial Outer Membrane Proteins; Burkholderia pseudomallei; Culture Media; Drug Resistance, Multiple, Bacterial; Humans; Membrane Transport Proteins; Microbial Sensitivity Tests; Mutation; Periplasmic Proteins; Quorum Sensing; Singapore; Virulence Factors	2010
Optimized Nile Red efflux assay of AcrAB-TolC multidrug efflux system shows competition between substrates. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:9 Topics: Anti-Bacterial Agents; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Chlortetracycline; Dipeptides; Doxorubicin; Doxycycline; Drug Resistance, Multiple, Bacterial; Escherichia coli; Escherichia coli Proteins; Minocycline; Onium Compounds; Organophosphorus Compounds; Tetracycline	2010
Interplay between drug efflux and antioxidants in Escherichia coli resistance to antibiotics. Antimicrobial agents and chemotherapy, 2010, Volume: 54, Issue:12 Topics: Aminoglycosides; Anti-Bacterial Agents; Antioxidants; Erythromycin; Escherichia coli; Glutathione; Kanamycin; Microbial Sensitivity Tests; Novobiocin; Spermidine	2010
Degradation of MAC13243 and studies of the interaction of resulting thiourea compounds with the lipoprotein targeting chaperone LolA. Bioorganic & medicinal chemistry letters, 2013, Apr-15, Volume: 23, Issue:8 Topics: Anti-Bacterial Agents; Escherichia coli; Escherichia coli Proteins; Lipoproteins; Molecular Chaperones; Periplasmic Binding Proteins; Structure-Activity Relationship; Thiourea	2013
Comparative in vitro activity of norfloxacin against resistant Neisseria gonorrhoeae. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology, 1989, Volume: 8, Issue:7 Topics: Ceftizoxime; Ceftriaxone; Drug Resistance, Microbial; Humans; Neisseria gonorrhoeae; Norfloxacin; Penicillin Resistance; Penicillinase; Penicillins; Spectinomycin; Tetracycline; Tetracycline Resistance	1989
In vitro antimicrobial sensitivity of Neisseria gonorrhoeae from Rwanda. Genitourinary medicine, 1986, Volume: 62, Issue:4 Topics: Anti-Bacterial Agents; Kanamycin; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Norfloxacin; Penicillin G; Penicillin Resistance; Penicillinase; R Factors; Rwanda; Spectinomycin; Tetracycline; Thiamphenicol	1986
The efficacy between spectinomycin and norfloxacin in the treatment of uncomplicated gonorrhoeae. Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1987, Volume: 70, Issue:11 Topics: Female; Gonorrhea; Humans; Norfloxacin; Prospective Studies; Random Allocation; Spectinomycin	1987
Treatment of penicillin-resistant Neisseria gonorrhoeae with oral norfloxacin. The New England journal of medicine, 1984, Jul-19, Volume: 311, Issue:3 Topics: Administration, Oral; Anti-Bacterial Agents; Drug Tolerance; Gonorrhea; Humans; Male; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Penicillin Resistance; Penicillins; Spectinomycin; Urethritis	1984
In vitro activities of the spectinomycin analog U-63366 and four quinolone derivatives against Neisseria gonorrhoeae. Antimicrobial agents and chemotherapy, 1984, Volume: 26, Issue:4 Topics: 4-Quinolones; Anti-Bacterial Agents; Ciprofloxacin; Microbial Sensitivity Tests; Nalidixic Acid; Neisseria gonorrhoeae; Norfloxacin; Quinolines; Quinolones; Spectinomycin	1984